M&R Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.17K Sell
427
-30
-7% -$622 ﹤0.01% 411
2024
Q2
$9.46K Hold
457
﹤0.01% 378
2024
Q1
$8.56K Sell
457
-936
-67% -$16.1K ﹤0.01% 383
2023
Q4
$20.1K Sell
1,393
-429
-24% -$5.84K 0.01% 320
2023
Q3
$31.6K Sell
1,822
-1,982
-52% -$41.3K 0.01% 271
2023
Q2
$79.2K Sell
3,804
-405
-10% -$8.8K 0.02% 209
2023
Q1
$99K Sell
4,209
-276
-6% -$7.41K 0.03% 183
2022
Q4
$125K Sell
4,485
-548
-11% -$14K 0.03% 170
2022
Q3
$117K Sell
5,033
-1,219
-19% -$36.8K 0.03% 174
2022
Q2
$211K Sell
6,252
-656
-9% -$23K 0.06% 138
2022
Q1
$241K Sell
6,908
-2,930
-30% -$100K 0.05% 140
2021
Q4
$299K Sell
9,838
-1,442
-13% -$47K 0.06% 130
2021
Q3
$369K Buy
+11,280
New +$361K 0.08% 113

Other funds holding OGN

M&R Capital Management's OGN Position: Q3 2024 in Review

M&R Capital Management reduced its Organon & Co (OGN) stake by 6.6% in Q3 2024, selling an estimated $622 and leaving 427 shares worth $8.17K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

M&R Capital Management first reported a position in OGN in Q3 2021 and has held it in 13 quarters since. The position peaked at $369K in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • M&R Capital Management held 427 shares of Organon & Co worth $8.17K as of Q3 2024.
  • M&R Capital Management sold 30 Organon & Co shares in Q3 2024, an estimated $622.
  • Organon & Co made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #411 holding.
  • M&R Capital Management first reported a position in Organon & Co in Q3 2021 and has held it in 13 quarters since.
  • M&R Capital Management's Organon & Co position peaked at $369K in Q3 2021.
  • 724 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.